Live Quote · OTCIMUCHealthcare· Biotechnology

EOM Pharmaceuticals Holdings, Inc.

$0.20 25.93%($-0.07)
TickerSpark Score
45/100
Weak
20
Valuation
40
Profitability
40
Growth
24
Health
100
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a IMUC research report →

52-Week Range54% of range
Low
$0.04
Current
$0.20
High
$0.34
Company Overviewwww.eompharma.com

About the company

EOM Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medications. These treatments hold the potential to revolutionize existing therapeutic approaches.

CEO
Irach Taraporewala
IPO
2021
Employees
3
HQ
Montvale, NJ, US

Price Chart

+181.29% · this period
$0.27$0.16$0.04Jul 02Dec 31Jul 02
Valuation
Market Cap
$25.30M
P/E
-13.16
P/S
0.00
P/B
-10.57
EV/EBITDA
-14.79
Div Yield
0.00%
Profitability
Gross Margin
0.00%
Op Margin
0.00%
Net Margin
0.00%
ROE
127.66%
ROIC
287.57%
Growth & Income
Revenue
$0 · 0.00%
Net Income
$-1,922,557 · -1.61%
EPS
$-0.02 · 7.32%
Op Income
$-1,827,547
FCF YoY
44.25%
Performance & Tape
52W High
$0.34
52W Low
$0.04
50D MA
$0.16
200D MA
$0.15
Beta
0.15
Avg Volume
7.43K

Get TickerSpark's AI analysis on IMUC

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 6, 18Yu John Sother120,000
Dec 31, 16Gengos Andrewother3,284
Jun 17, 16Yu John Sother156,750
Jun 17, 16Titus Garyother156,750
Jun 17, 16Singhvi Rahulother156,750
Jun 17, 16SCHLOSSBERG MARK Aother156,750
Jun 17, 16LAPOINTE ANTHONY GREGGother156,750
Mar 11, 16Swanson Steven Jother150,000
Mar 11, 16Swanson Steven Jother25,000
Mar 11, 16FRACTOR DAVIDother100,000
Coverage · IMUC

Our IMUC coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on IMUC yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate IMUC report →
Internal Compare

Similar companies

Peers in the same neighborhood.